LexisNexis® Risk Solutions, a leading provider of data and analytics for the insurance and automotive industries, and IMS, a global connected insurance technology company, today announced the ...

AbbVie (ABBV) announced it will present full Phase 3 results for its Etentamig, its investigational CMA x CD3 bispecific T-cell engager at the 23rd International Myeloma Society (IMS) Annual Meeting ...

HELSINKI, Sept. 18, 2026 Proof of concept shows how customers can complete an important service task even when they cannot answer a call Scailarc, Nokia and Elisa have completed a proof-of-concept ...

NOAA Fisheries' science-based conservation and management of sustainable fisheries, marine mammals, endangered species, and their habitats have become global models for marine stewardship and ...

The average daily trading volume for IMS SA (IMS) is 5,692. The opening price for IMS SA today was 2.31.

Select the degree and field of study (if applicable) to view the qualifications necessary for admission to your program of interest. The Master of Science in Health Data Science combines rigorous ...

A database is one or more sets of data, for example numbers, characters and images, bundled together with software that enables data to be added, removed or retrieved. Databases can be used to store ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A genetic database is one or more sets of genetic data (genes, gene products, variants, phenotypes) stored together with software to enable users to retrieve genetic data, add genetic data and extract ...

Plenary presentation will feature Phase 3 CERVINO results demonstrating that etentamig met the study's dual primary endpoints of objective response rate (ORR) and progression-free survival (PFS) in ...

Urban heat islands are a solvable data problem: this piece shows how to combine free satellite imagery, standard ...

The expert knowledge presented at this year’s International Myeloma Society (IMS) annual meeting focused on minimal residual disease testing and status, defining and treating high-risk disease, ...